Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
Wave Life Sciences (Nasdaq: WVE), a clinical-stage biotechnology company focusing on RNA medicines, has announced its upcoming second quarter 2024 financial results release. The company will host a live webcast and conference call on Thursday, August 8, 2024, at 8:30 a.m. ET to discuss the results and provide business updates.
Investors and interested parties can access the webcast through the 'Investor Events' section of the company's website. Analysts wishing to participate in the Q&A session can join via a provided audio conferencing link. An archived version of the webcast will be available on the company's website following the live event.
Wave Life Sciences (Nasdaq: WVE), un'azienda biotecnologica in fase clinica focalizzata sui farmaci a base di RNA, ha annunciato la prossima pubblicazione dei risultati finanziari per il secondo trimestre del 2024. L'azienda ospiterà un webcast dal vivo e una conferenza telefonica giovedì 8 agosto 2024, alle 8:30 ET per discutere i risultati e fornire aggiornamenti aziendali.
Investitori e parti interessate possono accedere al webcast attraverso la sezione 'Eventi per Investitori' del sito web dell'azienda. Gli analisti che desiderano partecipare alla sessione di domande e risposte possono unirsi tramite un link per la conferenza audio fornito. Una versione archiviata del webcast sarà disponibile sul sito web dell'azienda dopo l'evento dal vivo.
Wave Life Sciences (Nasdaq: WVE), una empresa biotecnológica en etapa clínica centrada en medicamentos basados en RNA, ha anunciado la próxima publicación de sus resultados financieros del segundo trimestre de 2024. La compañía llevará a cabo un webcast en vivo y una conferencia telefónica el jueves 8 de agosto de 2024, a las 8:30 a.m. ET para discutir los resultados y proporcionar actualizaciones sobre el negocio.
Los inversores y partes interesadas pueden acceder al webcast a través de la sección 'Eventos para Inversores' en el sitio web de la empresa. Los analistas que deseen participar en la sesión de preguntas y respuestas pueden unirse a través de un enlace de conferencia de audio proporcionado. Una versión archivada del webcast estará disponible en el sitio web de la compañía después del evento en vivo.
웨이브 라이프 사이언스 (Nasdaq: WVE), RNA 의약품에 중점을 둔 임상 단계의 생명공학 회사가 2024년 2분기 재무 결과 발표를 예정하고 있다고 발표했습니다. 이 회사는 2024년 8월 8일 목요일 오전 8시 30분 ET에 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 라이브 웹캐스트 및 전화 회의를 개최할 예정입니다.
투자자 및 이해관계자는 회사 웹사이트의 '투자자 이벤트' 섹션을 통해 웹캐스트에 접속할 수 있습니다. Q&A 세션에 참여하고 싶은 분석가는 제공된 오디오 회의 링크를 통해 참여할 수 있습니다. 라이브 이벤트 후 회사 웹사이트에서 웹캐스트의 아카이브 버전을 이용할 수 있습니다.
Wave Life Sciences (Nasdaq: WVE), une société de biotechnologie au stade clinique axée sur les médicaments à base d’ARN, a annoncé la prochaine publication de ses résultats financiers pour le deuxième trimestre de 2024. L’entreprise organisera un webinaire en direct et une conférence téléphonique le jeudi 8 août 2024 à 8h30 ET pour discuter des résultats et fournir des mises à jour sur les affaires.
Les investisseurs et les parties intéressées peuvent accéder au webinaire via la section 'Événements pour les Investisseurs' du site web de la société. Les analystes souhaitant participer à la session de questions-réponses peuvent rejoindre via un lien de conférence audio fourni. Une version archivée du webinaire sera disponible sur le site internet de l’entreprise après l'événement en direct.
Wave Life Sciences (Nasdaq: WVE), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf RNA-Medikamente konzentriert, hat die bevorstehende Veröffentlichung seiner finanziellen Ergebnisse für das zweite Quartal 2024 angekündigt. Das Unternehmen wird am Donnerstag, den 8. August 2024, um 8:30 Uhr ET einen Live-Webcast und eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen und Geschäftsnachrichten zu vermitteln.
Investoren und interessierte Parteien können über den Bereich 'Investorenveranstaltungen' der Unternehmenswebsite auf den Webcast zugreifen. Analysten, die an der Q&A-Sitzung teilnehmen möchten, können über den bereitgestellten Audio-Konferenzlink beitreten. Eine archivierte Version des Webcasts wird nach der Live-Veranstaltung auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, August 8, 2024, to review the company’s second quarter 2024 financial results and provide business updates.
The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: ir.wavelifesciences.com/events-publications/events.
Analysts planning to participate during the Q&A portion of the live call can join the conference call at the following audio conferencing link: available here. Once registered, participants will receive the dial-in information.
Following the live event, an archived version of the webcast will be available on the Wave Life Sciences website.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave’s RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Wave’s diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. Driven by the calling to “Reimagine Possible”, Wave is leading the charge toward a world in which human potential is no longer hindered by the burden of disease. Wave is headquartered in Cambridge, MA. For more information on Wave’s science, pipeline and people, please visit www.wavelifesciences.com and follow Wave on X (formerly Twitter) and LinkedIn.
Investor Contact:
Kate Rausch
+1 617-949-4827
krausch@wavelifesci.com
Media Contact:
Alicia Suter
+1 617-949-4817
asuter@wavelifesci.com
FAQ
When will Wave Life Sciences (WVE) release its Q2 2024 financial results?
What time is Wave Life Sciences' (WVE) Q2 2024 earnings call scheduled for?
How can investors access Wave Life Sciences' (WVE) Q2 2024 earnings webcast?
Will there be a replay available for Wave Life Sciences' (WVE) Q2 2024 earnings call?
